Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma
Abstract Background we have recently shown that Tel-eVax, a genetic vaccine targeting dog telomerase (dTERT) and based on Adenovirus (Ad)/DNA Electro-Gene-Transfer (DNA–EGT) technology can induce strong immune response and increase overall survival (OS) of dogs affected by multicentric Diffuse Large...
Main Authors: | Joseph A. Impellizeri, Alessandra Gavazza, Eliana Greissworth, Anna Crispo, Maurizio Montella, Gennaro Ciliberto, George Lubas, Luigi Aurisicchio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-018-1738-6 |
Similar Items
-
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
by: Federico D’Alessio, et al.
Published: (2023-03-01) -
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
by: Sogand Vahidi, et al.
Published: (2024-12-01) -
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma
by: Qiangan Jing, et al.
Published: (2025-01-01) -
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
by: Vincenzo Di Nunno, et al.
Published: (2023-12-01) -
Ovarian Telomerase and Female Fertility
by: Simon Toupance, et al.
Published: (2021-07-01)